AstraZeneca | Investor Day Presentation Deck

Slide schematic 4/4

diagram 1/1 source-note 1/1 title 2/2

Components 4

process source-note action-title headline

Tools 1

diagram/process: Clinical development matrix showing treatment lines (Neo-adjuvant, 1L, 2L, 3L) vs cancer types (HER2-low, HER2-positive, Beyond breast cancer)

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

roadmap 90%

The slide maps clinical development phases over time/treatment lines.

Find anything

The slide uses a matrix-like layout to map clinical trial phases and treatment strategies against patient segments.